A child with progressive dystonia, dysarthria, and spasticity

Reviews in Neurological Diseases

Volumn 7, Issue 1, 2010, Pages

  Schrock, Lauren E ^a   Ostrem, Jill L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Basal ganglia lesion; Dystonia; Neurodegeneration with brain iron accumulation; Pantothenate kinase associated neurodegeneration

Indexed keywords

ALPRAZOLAM; BACLOFEN; TRIHEXYPHENIDYL;

ADOLESCENT; ATTENTION DEFICIT DISORDER; BALANCE IMPAIRMENT; CASE REPORT; CHILDHOOD DISEASE; CONSERVATIVE TREATMENT; CONTRACTURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DYSARTHRIA; DYSTONIA; GAIT DISORDER; GENETIC SCREENING; HUMAN; IRON CHELATION; LEARNING DISORDER; MALE; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION; REVIEW; SCOLIOSIS; SPASTICITY; STOMACH TUBE; TENDON SURGERY;

ADOLESCENT; BASAL GANGLIA; DEGLUTITION DISORDERS; DIAGNOSIS, DIFFERENTIAL; DYSARTHRIA; DYSTONIA; GAIT DISORDERS, NEUROLOGIC; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE SPASTICITY; PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION; SUBSTANTIA NIGRA;

EID: 77954422336     PISSN: 15452913     EISSN: None     Source Type: Journal    
DOI: 10.3909/rind0239a     Document Type: Review

References (10)

1. Gregory A, Polster BJ, Hayflick SJ. Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J Med Genet. 2009;46:73-80.
2. Zhou B, Westaway SK, Levinson B, et al. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet. 2001;28:345-349.
3. Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med. 2003;348:33-40. (Pubitemid 36026344)
4. Harris ZL, Takahashi Y, Miyajima H, et al. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci U S A. 1995;92:2539-2543.
5. Curtis AR, Fey C, Morris CM, et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet. 2001;28:350-354.
6. Gregory A, Westaway SK, Holm IE, et al. Neurodegeneration associated with genetic defects in phospholipase A(2). Neurology. 2008;71:1402-1409.
7. Morgan NV, Westaway SK, Morton JE, et al. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet. 2006;38:752-754.
8. McNeill A, Birchall D, Hayflick SJ, et al. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology. 2008;70:1614-1619.
9. Castelnau P, Cif L, Valente EM, et al. Pallidal stimulation improves pantothenate kinase-associated neurodegeneration. Ann Neurol. 2005;57:738-741. (Pubitemid 40628863)
10. Forni GL, Balocco M, Cremonesi L, et al. Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation. Mov Disord. 2008;23:904-907.